JP2011502121A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502121A5
JP2011502121A5 JP2010531066A JP2010531066A JP2011502121A5 JP 2011502121 A5 JP2011502121 A5 JP 2011502121A5 JP 2010531066 A JP2010531066 A JP 2010531066A JP 2010531066 A JP2010531066 A JP 2010531066A JP 2011502121 A5 JP2011502121 A5 JP 2011502121A5
Authority
JP
Japan
Prior art keywords
peptide
composition
seq
amino acid
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010531066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502121A (ja
JP5379806B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/012191 external-priority patent/WO2009058244A1/en
Publication of JP2011502121A publication Critical patent/JP2011502121A/ja
Publication of JP2011502121A5 publication Critical patent/JP2011502121A5/ja
Application granted granted Critical
Publication of JP5379806B2 publication Critical patent/JP5379806B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010531066A 2007-10-29 2008-10-28 皮膚の保護ケア用テトラペプチド Active JP5379806B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81507P 2007-10-29 2007-10-29
US61/000,815 2007-10-29
PCT/US2008/012191 WO2009058244A1 (en) 2007-10-29 2008-10-28 Protective skin care tetrapeptides

Publications (3)

Publication Number Publication Date
JP2011502121A JP2011502121A (ja) 2011-01-20
JP2011502121A5 true JP2011502121A5 (enExample) 2011-10-13
JP5379806B2 JP5379806B2 (ja) 2013-12-25

Family

ID=40305326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010531066A Active JP5379806B2 (ja) 2007-10-29 2008-10-28 皮膚の保護ケア用テトラペプチド

Country Status (9)

Country Link
US (1) US8071555B2 (enExample)
EP (1) EP2205623B1 (enExample)
JP (1) JP5379806B2 (enExample)
KR (1) KR101668803B1 (enExample)
CN (1) CN101855235B (enExample)
CA (1) CA2701420C (enExample)
ES (1) ES2567706T3 (enExample)
PL (1) PL2205623T3 (enExample)
WO (1) WO2009058244A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1994155T4 (da) 2006-02-13 2022-07-25 Daiichi Sankyo Co Ltd Polynukleotid- og polypeptidsekvenser involveret i fremgangsmåden med knogleremodellering
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
EP2065029B1 (en) * 2007-11-30 2013-04-17 Evonik Goldschmidt GmbH Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K
KR20220106862A (ko) 2011-06-24 2022-07-29 노노 인코포레이티드 허혈에 대한 psd-95 억제제와의 조합 요법
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
CN104254339B (zh) * 2012-04-16 2020-01-21 路博润高级材料公司 用于治疗和/或护理皮肤和/或粘膜的化合物和它们在化妆品组合物或药物组合物中的用途
US9493562B2 (en) 2012-07-19 2016-11-15 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies
RU2687151C2 (ru) * 2013-06-14 2019-05-07 Хеликс Биомедикс Инк. Тетрапептиды, полученные из с-х-с-хемокинов человека, подходящие для лечения различных состояний кожи
KR20150130616A (ko) * 2014-05-13 2015-11-24 (주)케어젠 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도
US9636292B2 (en) 2015-07-30 2017-05-02 Truth Aesthetics LLC Topical skin care composition for night use
US9351911B1 (en) 2015-07-30 2016-05-31 Truth Aesthetics LLC Topical skin care composition providing broad spectrum sunscreen
CN107629111B (zh) * 2017-10-26 2021-06-04 陕西慧康生物科技有限责任公司 一种乙酰基四肽-2的液相合成方法
CA3120624A1 (en) * 2018-11-30 2020-06-04 Interk Peptide Therapeutics Limited Polypeptides and methods for improving skin conditions
KR102120992B1 (ko) * 2019-05-03 2020-06-10 (주)위바이오트리 신규한 금속 층상수산화물 복합체 및 이의 제조방법
IT201900008364A1 (it) * 2019-06-07 2020-12-07 Espikem S R L Peptidi bioattivi e composizioni che li comprendono
KR102778423B1 (ko) * 2019-09-26 2025-03-10 (주)아모레퍼시픽 피부 각질세포의 항노화 물질 스크리닝 방법, 스크리닝 키트 및 피부 각질세포의 항노화 물질 함유 조성물
EP4001294A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
FR3123193B1 (fr) * 2021-05-28 2025-11-07 Oreal Procédé d’électroporation pour délivrer une composition comprenant au moins un peptide de poids moléculaire allant de 500 Da à 20 kDa
WO2023212118A1 (en) * 2022-04-27 2023-11-02 Sbla Brands Inc. Anti-aging peptide containing cosmetic

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1357121A (en) * 1970-07-28 1974-06-19 Squibb & Sons Inc Peptide enzyme inhibitors
GB2208511A (en) 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
DE68918388T2 (de) 1988-04-21 1995-03-02 Uab Research Foundation Bioelastomer ohne adhäsionseigenschaft zum einsatz am wundort.
ATE189231T1 (de) 1989-04-10 2000-02-15 Helix Biomedix Inc Lytische peptide, verwendung als wachstumsfördernde mittel und für infektionen und krebs
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5464820A (en) 1993-06-22 1995-11-07 The University Hospital Specific inhibitors of tissue kallikrein
US5763576A (en) 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
FR2741076B1 (fr) 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
EP0858808B1 (en) 1997-01-17 2003-04-02 Johnson & Johnson Medical Ltd. Peptides for use in wound treatment
GB9702943D0 (en) 1997-02-13 1997-04-02 Univ Manchester Wound healing
SE9701162D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
US6143742A (en) 1997-12-11 2000-11-07 Fuisz Technologies Ltd Treatment for necrotizing infections
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
AU1170899A (en) 1998-04-01 1999-10-18 Biotech Australia Pty Limited Use of protease inhibitors for treating skin wounds
CA2312075A1 (en) 1998-11-05 2001-12-22 Protease Sciences, Incorporated Cosmetic compositions containing human type serine protease inhibitors
US6096327A (en) 1998-11-05 2000-08-01 Protease Sciences Inc. Cosmetic compositions containing human type serine protease inhibitors for revitalizing the skin
FR2788777B1 (fr) * 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6284802B1 (en) 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
CA2276542C (en) 1999-06-28 2013-07-30 Vladislav I. Deigin Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6537968B1 (en) 2000-07-24 2003-03-25 Alphamed Pharmaceuticals Corp Treatment of lupus erythematosus
GB0029777D0 (en) 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
EP2105141B1 (en) 2001-03-28 2012-08-08 Helix Biomedix, Inc. Short bioactive peptides and methods for their use
US20040167072A1 (en) 2001-05-11 2004-08-26 Aggarwal Bharat B. Inhibitors of receptor activator of NF-kappaB and uses thereof
AU2002256518B2 (en) * 2001-05-11 2007-07-19 Research Development Foundation Inhibitors of receptor activator of NF-kappaB and uses thereof
US7238656B2 (en) 2001-08-29 2007-07-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Protective factors against inflammation, burns and noxious stimuli
US7041506B2 (en) 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
JP2005519587A (ja) 2001-11-28 2005-07-07 ベクトン・ディキンソン・アンド・カンパニー 増殖阻害作用を有するペプチド
US20040009911A1 (en) 2002-01-31 2004-01-15 Irm, Llc Hepsin substrates and prodrugs
WO2003093314A2 (en) 2002-05-03 2003-11-13 Millenium Biologix Inc. Connective tissue stimulating peptides
US7265097B2 (en) 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers
US7541440B2 (en) 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
KR101045658B1 (ko) 2003-11-17 2011-07-01 쎄데르마 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물
DE102004050563A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Kosmetische und der dermatologische Zusammensetzungen mit Wirkstoffen für einen verbesserten Hautkomfort
DE102005000868A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren
DE202004012807U1 (de) 2004-08-13 2004-10-21 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden
DE102004055541A1 (de) 2004-11-17 2006-05-18 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut
US7271239B2 (en) 2004-09-01 2007-09-18 The Research Foundation Of State University Of New York D-isomers of antimicrobial peptide
US20060046271A1 (en) 2004-09-02 2006-03-02 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
US20070224150A1 (en) 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
FR2884418B1 (fr) 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
AU2006266609C1 (en) 2005-07-05 2011-10-27 Biotempt B.V. Treatment of tumors
US20070077305A1 (en) 2005-10-03 2007-04-05 Le Tien C Biocompatible polymeric matrix and preparation thereof
DE102005063062A1 (de) 2005-12-29 2007-07-05 Henkel Kgaa Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
US7807625B2 (en) 2006-01-18 2010-10-05 Grant Industries, Inc Anti-wrinkle composition
WO2007098255A2 (en) * 2006-02-21 2007-08-30 President And Fellows Of Harvard College Compositions for and methods of identifying antigens

Similar Documents

Publication Publication Date Title
JP2011502121A5 (enExample)
Song et al. The effect of caffeic acid on wound healing in skin-incised mice
JP5379806B2 (ja) 皮膚の保護ケア用テトラペプチド
KR102236805B1 (ko) Hc-ha/ptx3 복합체를 함유하는 조성물 및 이의 사용 방법
Gao et al. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis
Li et al. OM‐LV20, a novel peptide from odorous frog skin, accelerates wound healing in vitro and in vivo
KR101988675B1 (ko) 피부 및/또는 점막의 치료 및/또는 관리에 유용한 펩티드 및 화장품학적 또는 약제학적 조성물에 있어서의 이의 용도
US12269865B2 (en) Recombinant elastin and production thereof
RU2012103653A (ru) Композиция кожного препарата для наружного применения
CN105273081B (zh) 一种二肽基肽酶iv抑制肽及其制备和应用
RS53326B (sr) Antimikrobna jedinjenja
US20210401751A1 (en) Compositions for treating viral infections and methods for same
EP3007716A1 (en) Tetrapeptides derived from human c-x-c chemokines useful for treatment of various skin conditions
AU2007342353B2 (en) Short bio-active peptides for cellular and immunological modulation
JP6548126B2 (ja) Ｉｉｉ型コラーゲン産生促進剤
WO2013042811A1 (ko) 카페오일알파네오엔돌핀 펩타이드 유도체 및 이의 항가려움 및 항아토피 소재로의 활용
KR20220117256A (ko) 펩타이드 및 염증 치료에서의 이의 용도
KR102211099B1 (ko) 기능성 리포펩타이드를 포함하는 피부 개선용 화장료 조성물
WO2024260465A1 (en) New multi-functional oligopeptides
RU2012125260A (ru) Пептидная защита против токсического воздействия ультрафиолетового излучения
AU2021200731B2 (en) Pro-drug peptide with improved pharmaceutical properties
JPWO2007148831A1 (ja) 亜鉛を有効成分として含有するコラーゲン合成促進剤
ATE544779T1 (de) Neue, die migration dendritischer zellen induzierende polypeptide, sowie medikamente und pharmazeutische zusammensetzungen, die diese enthalten
ES2385683A1 (es) Composiciones para el tratamiento del dolor y/o la inflamación.
SE0700513L (sv) Kosmetiska kompositioner